EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort

Adrian Włodarczak, Piotr Rola iD, Mateusz Barycki, Łukasz Furtan, Magdalena Łanocha, Szymon Włodarczak, Marek Szudrowicz, Jan Jakub Kulczycki, Joanna Jaroszewska-Pozorska, Michalina Kędzierska, Katarzyna Giniewicz, Adrian Doroszko und 1 weitere

Diabetes and Vascular Disease Research · 2023

DOI: 10.1177/14791641231188705 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes and Vascular Disease Research, 2023. Verfasst von Adrian Włodarczak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences and Physical Culture, Witelon Collegium State University, Legnica, Poland. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Drug-Eluting Stents, Percutaneous Coronary Intervention, Diabetes Mellitus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes type 2 is one of the strongest risk factors affecting coronary artery disease (CAD) and is also a marker of poor short and long-term prognosis in subjects with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) with subsequent drug-eluting stent (DES) implantation. Chronic local vascular inflammation along with endothelial dysfunction is postulated to be the pathophysiological background of unfavorable results. The second generation of metallic magnesium BRS –Magmaris (Biotronik, Berlin, Germany) had been introduced to clinical practice to overcome these limitations.

Methods

We evaluated 2-years clinical outcomes after Magmaris BRS implantation in NSTE-ACS diabetic ( n-72) and non-diabetic ( n-121) cohorts.

Results

No significant differences between diabetic and non-diabetes cohorts were noticed in terms of Primary Outcome (cardiac death, myocardial infarction, stent thrombosis) (8.1% vs 3.3% p = 0.182) and Principal secondary outcome – TLF- target lesion failure (9.5% vs 3.3% p = 0.106) at 2-years follow-up.

Conclusions

2-years outcome suggests good safety and efficacy of the magnesium BRS (Magmaris) in NSTE- ACS and concomitant DM. Nevertheless, there is a strong need for large multicenter, randomized, prospective studies for a full assessment of this novel device in diabetic patients with ACS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeDrug-Eluting StentsPercutaneous Coronary InterventionDiabetes MellitusHumansMagnesiumAbsorbable ImplantsProspective StudiesInflammation

Stichwörter der Autor:innen

Diabetes mellitus (DM)acute coronary syndrome (ACS)bioresorbable materialscoronary artery disease (CAD)magmarismagnesium bioresorbable scaffold (BRS)mid-term outcomepercutaneous coronary intervention (PCI)

Substanzen

Magnesium

Autor:innen und Institutionen

  • Faculty of Health Sciences and Physical Culture, Witelon Collegium State University, Legnica, Poland.
  • Department of Cardiology, The Copper Health Centre (MCZ), Lubin, Poland.
  • Department of Cardiology, Provincial Specialized Hospital in Legnica, Legnica, Poland.
  • Adalbert's Hospital, Poznan, Poland.
  • Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
  • Professional Medical Statistician, Wrocław, Poland.

ORCID-Profile: Piotr Rola

Zitieren

APA

Włodarczak, A., Rola, P., Barycki, M., Furtan, Ł., Łanocha, M., Włodarczak, S., Szudrowicz, M., Kulczycki, J. J., Jaroszewska-Pozorska, J., Kędzierska, M., Giniewicz, K., Doroszko, A., & Lesiak, M. (2023). Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diabetes and Vascular Disease Research. https://doi.org/10.1177/14791641231188705

Vancouver

Włodarczak A, Rola P, Barycki M, Furtan Ł, Łanocha M, Włodarczak S, et al. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diabetes and Vascular Disease Research. 2023. doi:10.1177/14791641231188705

BibTeX
@article{Wodarczak2023,
  author = {Włodarczak, Adrian and Rola, Piotr and Barycki, Mateusz and Furtan, Łukasz and Łanocha, Magdalena and Włodarczak, Szymon and Szudrowicz, Marek and Kulczycki, Jan Jakub and Jaroszewska-Pozorska, Joanna and Kędzierska, Michalina and Giniewicz, Katarzyna and Doroszko, Adrian and Lesiak, Maciej},
  title = {Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort},
  journal = {Diabetes and Vascular Disease Research},
  year = {2023},
  doi = {10.1177/14791641231188705}
}
Kostenlos starten →